Last updated: 2026-09-14 15:26:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Sera Prognostics, Inc. (SERA) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $2,06, with a market capitalization of $80,08M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,56 to $3,95. This page covers its latest market performance, valuation, price trends and company information.
$80,08M | |
$2,04 | |
$15,50 | |
$1,10 | |
$2,03 | |
10,61K | |
34,10K | |
-- | |
$3,95 | |
$1,56 | |
-- | |
-- |
Sera Prognostics, Inc. (SERA) is currently trading at $2,06 as of 2026-09-14 15:05:38, up 1,23% ($0,03) from the previous close of $2,03
During today's regular trading session, SERA has traded between $1,10 and $15,50, with a trading volume of 10,61K shares. The current price is near the lower end of today's range.
Over the past seven days, Sera Prognostics, Inc. (SERA) moved from $2,01 to $2,06, representing a gain of 2,24% ($0,05).
The stock traded between $1,97 and $2,18 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 30,28 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 20,7%
SERA is currently trading at $2,06, placing it 20,7% of the way from its 52-week low of $1,56 to its 52-week high of $3,95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 72 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sera Prognostics, Inc. (SERA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.